Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease
- PMID: 12898349
- DOI: 10.1007/s00702-003-0007-9
Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease
Abstract
Choline containing phospholipids are essential for the integrity of the'cell'membrane. Minor changes in the lysophosphatidylcholine (lyso-PC)/phosphatidylcholine (PC) ratio may lead to neuronal damage and cell loss. Several studies have shown protein and lipid oxidation in Alzheimer's disease (AD) affected brain regions. Amyloid-beta peptides may induce free-radical oxidative stress which normally is counteracted by anti-oxidant defense mechanisms. We hypothesize that oxidation may lead to changed concentrations of choline containing phospholipids in cerebrospinal fluid (CSF) of AD patients, because of the susceptibility of the unsaturated acyl-chains of PC for oxidation. PC and lyso-PC were determined in CSF of AD patients (n=19) and subjects with subjective memory complaints without dementia (n=19) by tandem mass spectrometry. No differences in total PC concentrations were observed between both study groups. Furthermore, we could not demonstrate different concentrations of PC species containing linoleic acid and PC species containing arachidonic acid. Interestingly, lyso-PC concentrations tended to be lower while the lyso-PC/PC ratio was significantly decreased in CSF of AD patients compared to controls (0.36% versus 0.54%; P=0.017). A comparable decrease was found for the lyso-PC/PC ratio for PC containing linoleic acid (P=0.022) or arachidonic acid (P=0.010), respectively. The lower lyso-PC/PC ratio in CSF of patients with AD may reflect alterations in the metabolism of choline-containing phospholipids in the brain in AD, and suggests that PC species containing linoleic acid or arachidonic acid are equally involved.
Similar articles
-
From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.J Chromatogr A. 2011 Oct 21;1218(42):7713-22. doi: 10.1016/j.chroma.2011.07.073. Epub 2011 Jul 30. J Chromatogr A. 2011. PMID: 21872257
-
Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.J Alzheimers Dis. 2013;36(1):155-63. doi: 10.3233/JAD-120778. J Alzheimers Dis. 2013. PMID: 23579327
-
DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.Sci Rep. 2014 Nov 20;4:7130. doi: 10.1038/srep07130. Sci Rep. 2014. PMID: 25410733 Free PMC article.
-
Phosphatidylcholine as a precursor of choline for acetylcholine synthesis.J Neural Transm Suppl. 1987;24:247-59. J Neural Transm Suppl. 1987. PMID: 3316498 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Statistically Driven Metabolite and Lipid Profiling of Patients from the Undiagnosed Diseases Network.Anal Chem. 2020 Jan 21;92(2):1796-1803. doi: 10.1021/acs.analchem.9b03522. Epub 2019 Dec 5. Anal Chem. 2020. PMID: 31742994 Free PMC article.
-
Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.Biochim Biophys Acta. 2010 Aug;1801(8):774-83. doi: 10.1016/j.bbalip.2010.01.010. Epub 2010 Feb 1. Biochim Biophys Acta. 2010. PMID: 20117236 Free PMC article. Review.
-
Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.Int J Mol Sci. 2021 Oct 20;22(21):11313. doi: 10.3390/ijms222111313. Int J Mol Sci. 2021. PMID: 34768742 Free PMC article. Review.
-
Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function.PLoS One. 2016 Mar 25;11(3):e0151802. doi: 10.1371/journal.pone.0151802. eCollection 2016. PLoS One. 2016. PMID: 27015085 Free PMC article.
-
Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.Molecules. 2023 Feb 25;28(5):2166. doi: 10.3390/molecules28052166. Molecules. 2023. PMID: 36903413 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
